THIS MONTH’S ISSUE

Read, save, and print articles from the current issue

ARTICLES

Chronological index
2013–2016

PRODUCT GUIDES

Compare all instruments
and software systems

DEPARTMENTS

Chronological index
2013–2016

MARKETPLACE

New pathology lab products and industry news

Home » Top news

Sysmex acquires OGT

June 16, 2017Sysmex has reached an agreement with Oxford Gene Technology to acquire all shares in OGT, which will become a wholly owned subsidiary of Sysmex. With this acquisition, Sysmex aims to obtain OGT’s business and expertise in the cytogenetics domain and its reagent development capabilities used in next-generation sequencers, thereby reinforcing its base in the life science business. Sysmex plans to provide a unique solution in the cytogenetics market by fusing its flow fluorescence in situ hybridization and other automation technologies with OGT’s expertise in the development of high-quality reagents. By obtaining OGT’s NGS reagent development capabilities, Sysmex aims to reinforce its technology base in genomic medicine.

More top news

Print Friendly
Tags: ,

X